Salesforce
CRM
Apple
AAPL
Microsoft
MSFT
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
NKTR Nektar Therapeutics
- 1.0000
- -0.0200-1.96%
Close Dec 12 16:00 ET
184.46MMarket Cap-1.19P/E (TTM)
1.0400High1.0000Low2.16MVolume1.0200Open1.0200Pre Close2.21MTurnover1.30%Turnover RatioLossP/E (Static)184.46MShares1.928052wk High3.77P/B166.42MFloat Cap0.460852wk Low--Dividend TTM166.42MShs Float111.3600Historical High--Div YieldTTM3.92%Amplitude0.4126Historical Low1.0230Avg Price1Lot Size
About Nektar Therapeutics Company
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.
Company Profile
SymbolNKTR
Company NameNektar Therapeutics
Listing DateMay 6, 1994
Issue Price7.50
Founded1990
CEOMr. Howard W. Robin
MarketNASDAQ
Employees137
Fiscal Year Ends12-31
Address455 Mission Bay Boulevard South
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-482-5300
Websitehttp://www.nektar.com
Company Executives
- Name
- Position
- Salary
- Howard W. Robin
- Director, President and Chief Executive Officer
- 3.14M
- Mark Andrew Wilson, J.D.
- Senior Vice President and Chief Legal Officer
- 1.10M
- Sandra A. Gardiner
- Interim Chief Financial Officer and Principal Accounting Officer
- 376.30K
- Dr. Jonathan Zalevsky, PhD
- Chief Research and Development Officer
- 1.77M
- Robert B. Chess
- Chairman of the Board
- 176.22K
- R. Scott Greer
- Independent Director
- 170.22K
- Jeffrey R. Ajer
- Independent Director
- 134.22K
- Dr. Myriam J. Curet, M.D.
- Independent Director
- 118.22K
- Dr. Diana M. Brainard, M.D.
- Independent Director
- 112.72K
- Roy A. Whitfield
- Lead Independent Director
- 170.22K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.